Renalytix (RENX)

[ADVERT]
Company name:Renalytix Plc
EPIC:RENXTrading Currency:GBX
Market Sector:AIMPISIN:GB00BYWL4Y04
Market Segment:ASX1Share Type:DE
WWW Address:http://renalytixai.com/investors/Description:ORD 0.25P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 1,045.00 images.advfn.com/imagesnew/2/gb/dot 0.0 [0.00] 1,010.00 1,080.00 1,045.00 1,070.00 1,045.00 2,716
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 754.75 72.22 0.05 -16.00 - - - 1,220.00 - 415.00

Renalytix Key Figures

(at previous day's close)
Market Cap.754.75m
Shares In Issue72.22m
Prev. Close1,045.00
PE Ratio- 
Dividend Yield-%
EPS - basic-16.00p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-13.93p
Return On Equity (ROE)-25.72%
Operating Margin-%
PEG Factor- 
EPS Growth Rate-1,500.00%
Dividends PS Growth Rate-%
Net Debt-7.96m
Gross Gearing12.92%
Quick Assets19.99m
Net Working Capital16.93m
Intangibles / Fixed Assets83.32%
Turnover PS-p
Pre-Tax Profit PS-14.69p
Retained Profit PS-12.81p
Cash PS18.41p
Net Cash PS13.72p
Net Tangible Asset Value PS *25.59p
Net Asset Value PS49.79p
Spread70.00 (6.48%) 

Renalytix Balance Sheet

L^RENX:Liabilities+EQL^RENX:Assets

Share Price Performance

Sample Period HighLow
1 week1,177.501,020.00
4 weeks1,177.50925.00
12 weeks1,220.00925.00
1 year1,220.00415.00

Share Price Chart (5 years)

Renalytix Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week1,135.00-90.00-7.931,020.000.071,120.73
4 weeks997.5047.504.76925.000.051,067.07
12 weeks1,005.0040.003.98925.000.091,138.85
26 weeks885.00160.0018.08850.000.081,064.02
1 year595.00450.0075.63415.000.10803.51
3 years120.00925.00770.8385.000.07594.49
5 years120.00925.00770.8385.000.07594.49

Renalytix Key Management Ratios

Renalytix Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 21.50 
Tobin's Q Ratio (excl. intangibles)43.82 
Dividend Yield-%
Market-to-Book Ratio20.99 
Price-to-Pre-Tax Profit PS-71.14 
Price-to-Retained Profit PS-81.59 
Price-to-Cash Flow PS-75.02 
Price-to-Sales PS- 
Price-to-Net Tangible Asset Value PS40.84 
Price-to-Cash PS56.78 
Net Working Capital PS23.44 
Price Pct to Working Capital PS44.57%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Renalytix Financial Ratios

(Leverage Ratios)
Debt Ratio5.15%
Debt-to-Equity Ratio0.05 
Debt-to-Equity Ratio (excl. Intgbl)0.11 
Debt-to-Equity Market Value0.00 
Net Gearing-19.27%
Net Gearing (excl. Intangibles)-33.41%
Gross Gearing12.92%
Gross Gearing (excl. Intangibles)22.41%
Gearing Under 1 Year8.19%
Gearing Under 1 Year (excl. Intgbl)14.21%
Assets/Equity1.15 
Cash/Equity36.96 
(Liquidity Ratios)
Net Working Capital to Total Assets41.00%
Current Ratio6.01 
Quick Ratio (Acid Test)5.91 
Liquidity Ratio3.93 
Cash & Equiv/Current Assets65.43%
(Solvency Ratios)
Enterprise Value743.41m
CFO/Sales- 
CFO/Attributable Profit- 
CFO/Assets-0.24 
CFO/Debt-1.89 
Total Debt/Equity Market Value0.01 
Total Debt/Sales- 
Total Debt/Pre-Tax Profit-0.50 
Total Debt5.34m
Total Debt/Net Current Assets0.32%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs1 
Beta (60-Mnth)Beta (36-Mnth)
0.05180.0516

Renalytix Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-27.98%
Return On Assets (ROA)-26.35%
Net Profit Margin-%
Assets Turnover- 
Return On Equity (ROE)-25.72%
Return On Investment (ROI)-28.00%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-%
(Asset Utilisation Multiples)
Shareholders Equity Turnover- 
Fixed Assets Turnover- 
Current Assets Turnover- 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales- 
Debtors-to-Sales-%
Debt Collection Period-Days

Renalytix Dividends

Sorry No Data Available

Renalytix Fundamentals

 30 Jun 2019 (GBP)30 Jun 2020 (GBP)
turnover----m
pre tax profit-0.42--10.61-m
attributable profit-0.42--9.25-m
retained profit-0.42--9.25-m
eps - basic (p)-1.00 -16.00 
eps - diluted (p)-1.00 -16.00 
dividends per share- - 

Renalytix Balance Sheet

 30 Jun 2019 (GBP)30 Jun 2020 (GBP)
L^RENX:Liabilities+EQL^RENX:AssetsL^RENX:Liabilities+EQL^RENX:Assets
 30 Jun 2019 (GBP)30 Jun 2020 (GBP)
ASSETS
fixed assets fixed assets0.280.96%0.581.40%m
intangibles intangibles18.2963.23%17.4842.33%m
fixed investments fixed investments--%2.927.07%m
current assets - other current assets - other0.110.38%1.714.13%m
stocks stocks--%0.330.79%m
debtors debtors0.963.32%4.9912.09%m
cash & securities cash & securities9.2932.11%13.2932.19%m
TOTAL28.92100%41.30100%m
LIABILITIES
creditors - short creditors - short0.762.61%3.388.19%m
creditors - long creditors - long--%1.954.73%m
creditors - other creditors - other--%--%m
subordinated loans subordinated loans--%--%m
insurance funds insurance funds--%--%m
TOTAL0.762.61%5.3412.92%m
EQUITY
ord cap, reserves ord cap, reserves28.1797.39%35.9687.08%m
prefs, minorities prefs, minorities--%--%m
TOTAL28.1797.39%35.9687.08%m
OTHER
NAV Basic- - 
NAV Diluted- - 

Renalytix Cash Flow Statement

30 Jun 2019 (GBP)30 Jun 2020 (GBP)
Operating CF-4.42-10.06m
Pre-Financing CF-20.47-10.55m
Retained CF9.296.00m

Renalytix Brokers

Broker infomation is not available for this class of stock.
ADVFN Advertorial
Your Recent History
LSE
RENX
Renalytix
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210805 12:39:33